Human and mouse Fas (APO-1/CD95) death receptor genes each contain a p53-responsive element that is activated by p53 mutants unable to induce apoptosis

被引:112
作者
Munsch, D
Watanabe-Fukunaga, R
Bourdon, JC
Nagata, S
May, E
Yonish-Rouach, E
Reisdorf, P
机构
[1] CEA, Lab Cancerol Mol, Dept Radiobiol & Radiopathol, Direct Sci Vie,CNRS,UMR 217, F-92265 Fontenay Aux Roses, France
[2] Osaka Univ, Sch Med, Dept Genet, Suita, Osaka 5650871, Japan
关键词
D O I
10.1074/jbc.275.6.3867
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
p53 is a tumor suppressor protein that induces apoptosis at least in part through its ability to act as a sequence-specific transactivator. This work reports that intron 1 of the mouse Fas death receptor gene contains a p53-responsive element (p53RE) that matches the p53 consensus sequence and that is located between nucleotides +1704 and +1723 from the transcription initiation site. This element is specifically bound by p53 and functions as a p53-dependent enhancer in mammalian or in yeast reporter gene assays. Contrary to bax, another known pro-apoptotic p53-target gene, both mouse and human FAS p53REs are still activated by the discriminatory P53 mutants Pro-175 and Ala-143, a class of mutants unable to induce apoptosis. We propose that p53-dependent up-regulation of Fas does not induce apoptosis per se but sensitizes the cell to other pro-apoptotic signal(s). The functional conservation of p53-dependent Fas up-regulation argues strongly in favor of its biological importance and suggests that murine models may be used to study further the in vivo role of Fas in the p53 response.
引用
收藏
页码:3867 / 3872
页数:6
相关论文
共 52 条
  • [11] Identification of human p53 mutations with differential effects on the bax and p21 promoters using functional assays in yeast
    Flaman, JM
    Robert, V
    Lenglet, S
    Moreau, V
    Iggo, R
    Frebourg, T
    [J]. ONCOGENE, 1998, 16 (10) : 1369 - 1372
  • [12] Friedlander P, 1996, MOL CELL BIOL, V16, P4961
  • [13] Fuchs EJ, 1997, CANCER RES, V57, P2550
  • [14] A TRANSCRIPTIONALLY ACTIVE DNA-BINDING SITE FOR HUMAN P53 PROTEIN COMPLEXES
    FUNK, WD
    PAK, DT
    KARAS, RH
    WRIGHT, WE
    SHAY, JW
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 1992, 12 (06) : 2866 - 2871
  • [15] NEW YEAST-ESCHERICHIA-COLI SHUTTLE VECTORS CONSTRUCTED WITH INVITRO MUTAGENIZED YEAST GENES LACKING 6-BASE PAIR RESTRICTION SITES
    GIETZ, RD
    SUGINO, A
    [J]. GENE, 1988, 74 (02) : 527 - 534
  • [16] p53 in growth control and neoplasia
    Gottlieb, TM
    Oren, M
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 1996, 1287 (2-3): : 77 - 102
  • [17] GREENBLATT MS, 1994, CANCER RES, V54, P4855
  • [18] HEME REGULATES TRANSCRIPTION OF THE CYC1 GENE OF S-CEREVISIAE VIA AN UPSTREAM ACTIVATION SITE
    GUARENTE, L
    MASON, T
    [J]. CELL, 1983, 32 (04) : 1279 - 1286
  • [19] TRANSFORMATION OF INTACT YEAST-CELLS TREATED WITH ALKALI CATIONS
    ITO, H
    FUKUDA, Y
    MURATA, K
    KIMURA, A
    [J]. JOURNAL OF BACTERIOLOGY, 1983, 153 (01) : 163 - 168
  • [20] IDENTIFICATION OF P53 AS A SEQUENCE-SPECIFIC DNA-BINDING PROTEIN
    KERN, SE
    KINZLER, KW
    BRUSKIN, A
    JAROSZ, D
    FRIEDMAN, P
    PRIVES, C
    VOGELSTEIN, B
    [J]. SCIENCE, 1991, 252 (5013) : 1708 - 1711